Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada.
In 2018, the global Ciclesonide market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Ciclesonide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ciclesonide development in United States, Europe and China.
The key players covered in this study
Covis Pharma
...
Market segment by Type, the product can be split into
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation
Market segment by Application, split into
Adults
Children
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ciclesonide status, future forecast, growth opportunity, key market and key players.
To present the Ciclesonide development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ciclesonide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ciclesonide Market Size Growth Rate by Type (2014-2025)
1.4.2 Inhalation Aerosol 37 mcg/actuation
1.4.3 Inhalation Aerosol 80 mcg/actuation
1.4.4 Inhalation Aerosol 120 mcg/actuation
1.4.5 Inhalation Aerosol 160 mcg/actuation
1.5 Market by Application
1.5.1 Global Ciclesonide Market Share by Application (2014-2025)
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ciclesonide Market Size
2.2 Ciclesonide Growth Trends by Regions
2.2.1 Ciclesonide Market Size by Regions (2014-2025)
2.2.2 Ciclesonide Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ciclesonide Market Size by Manufacturers
3.1.1 Global Ciclesonide Revenue by Manufacturers (2014-2019)
3.1.2 Global Ciclesonide Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ciclesonide Market Concentration Ratio (CR5 and HHI)
3.2 Ciclesonide Key Players Head office and Area Served
3.3 Key Players Ciclesonide Product/Solution/Service
3.4 Date of Enter into Ciclesonide Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ciclesonide Market Size by Type (2014-2019)
4.2 Global Ciclesonide Market Size by Application (2014-2019)
5 United States
5.1 United States Ciclesonide Market Size (2014-2019)
5.2 Ciclesonide Key Players in United States
5.3 United States Ciclesonide Market Size by Type
5.4 United States Ciclesonide Market Size by Application
6 Europe
6.1 Europe Ciclesonide Market Size (2014-2019)
6.2 Ciclesonide Key Players in Europe
6.3 Europe Ciclesonide Market Size by Type
6.4 Europe Ciclesonide Market Size by Application
7 China
7.1 China Ciclesonide Market Size (2014-2019)
7.2 Ciclesonide Key Players in China
7.3 China Ciclesonide Market Size by Type
7.4 China Ciclesonide Market Size by Application
8 Japan
8.1 Japan Ciclesonide Market Size (2014-2019)
8.2 Ciclesonide Key Players in Japan
8.3 Japan Ciclesonide Market Size by Type
8.4 Japan Ciclesonide Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ciclesonide Market Size (2014-2019)
9.2 Ciclesonide Key Players in Southeast Asia
9.3 Southeast Asia Ciclesonide Market Size by Type
9.4 Southeast Asia Ciclesonide Market Size by Application
10 India
10.1 India Ciclesonide Market Size (2014-2019)
10.2 Ciclesonide Key Players in India
10.3 India Ciclesonide Market Size by Type
10.4 India Ciclesonide Market Size by Application
11 Central & South America
11.1 Central & South America Ciclesonide Market Size (2014-2019)
11.2 Ciclesonide Key Players in Central & South America
11.3 Central & South America Ciclesonide Market Size by Type
11.4 Central & South America Ciclesonide Market Size by Application
12 International Players Profiles
12.1 Covis Pharma
12.1.1 Covis Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ciclesonide Introduction
12.1.4 Covis Pharma Revenue in Ciclesonide Business (2014-2019)
12.1.5 Covis Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
